Izokibep was effective in reducing disease activity among patients with HS, including those who switched to izokibep from ...

Dupilumab use among pediatric patients with moderate to severe AD is associated with a meaningful increase in weight ...

Women who deliver preterm have lower vitamin D concentrations than women who deliver at term, according to recent study results.

An investigational therapy, SSGJ-608, was associated with substantial skin clearance through 52 weeks among patients with plaque psoriasis.

Patients with NF1 have a greater prevalence of cherry angiomas than the general population and NF1 inactivation may contribute to their development.

The Food and Drug Administration expanded the approval of baricitinib to include those aged 12 years and older.

Patients with psoriasis who used biologic therapies had a lower risk for incident psoriatic arthritis than those who were biologic-naive.

Amgen’s phase 3 OASIZ 301 trial shows dazodalibep significantly improves systemic disease activity in adults with moderate to severe Sjögren disease at week 48.

Generalized pustular psoriasis is associated with elevated mortality and comorbidity risk compared with psoriasis vulgaris and controls.

The FDA has updated labeling for Kybella (deoxycholic acid) to warn clinicians of persistent nodules, masses, and adverse events linked to off-label use.

Research is needed on the real-world performance of clinical AI tools in dermatology, yet many patients use available consumer-facing tools.

Aminolevulinic acid hydrochloride in combination with photodynamic therapy has been approved for the treatment of BCC.